P24863 (CCNC_HUMAN) Homo sapiens (Human)
Cyclin-C UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
34 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of human CDK8/CYCC in complex with compound 11 (1-[3-tert-butyl-1-(4-methylphenyl… |
Heteromer P49336; | 100 | 1×0SV; 2×EDO; | |||
| Crystal structure of human CDK8/CYCC in complex with compound 5 (1-[3-tert-butyl-1-(4-methylphenyl)… |
Heteromer P49336; | 100 | 1×0SR; 1×NA; 1×DMS; 10×EDO; 6×FMT; | |||
| CDK8-CYCC IN COMPLEX WITH [(S)-2-(4-Chloro-phenyl)-pyrrolidin-1-yl]-(5-methyl-imidazo[5,1-b][1,3,4]… |
Heteromer P49336; | 100 | 1×69Z; 3×EDO; 9×FMT; | |||
| CRYSTAL STRUCTURE OF CDK8-CycC IN COMPLEX WITH BI00690300 |
Heteromer P49336; | 100 | 1×JRE; 1×EDO; 3×FMT; | |||
| CRYSTAL STRUCTURE OF CDK8-CycC IN COMPLEX WITH COMPOUND 1 |
Heteromer P49336; | 100 | 1×JRE; 1×EDO; 3×FMT; | |||
| Crystal structure of human CDK8/CYCC in the DMG-in conformation |
Heteromer P49336; | 100 | 1×0SW; 13×EDO; 1×FMT; | |||
| Crystal Structure of human CDK8/CycC |
Heteromer P49336; | 100 | 1×BAX; 11×EDO; 1×GOL; | |||
| Crystal structure of CDK8:Cyclin C complex with compound 22 |
Heteromer P49336; | 100 | 8×EDO; 7×FMT; 1×50R; | |||
| CDK8-CYCC IN COMPLEX WITH [(S)-2-(4-Chloro-phenyl)-pyrrolidin-1-yl]-(3-methyl-1H-pyrazolo[3,4-b]pyr… |
Heteromer P49336; | 100 | 1×6A7; 1×EDO; 6×FMT; | |||
| CDK8-CYCC IN COMPLEX WITH [6-Hydroxy-3-(3-methyl-benzyl)-1H-indazol-5-yl]-((S)-3-hydroxy-pyrrolidin… |
Heteromer P49336; | 100 | 1×62M; 6×FMT; 2×EDO; | |||
| CDK8-CYCC IN COMPLEX WITH 8-[3-(3-Amino-1H-indazol-6-yl)-5-chloro- pyridine-4-yl]-2,8-diaza-spiro[4… |
Heteromer P49336; | 100 | 1×5XG; 1×DMS; 2×EDO; 7×FMT; | |||
| CDK8-CYCC IN COMPLEX WITH 8-[3-Chloro-5-(1-methyl-2,2-dioxo-2, 3-dihydro-1H-2l6-benzo[c]isothiazol-… |
Heteromer P49336; | 100 | 1×5Y6; 1×DMS; 1×EDO; 4×FMT; | |||
| CDK8/CYCC IN COMPLEX WITH COMPOUND 20 |
Heteromer P49336; | 100 | 1×66X; 1×FMT; 2×CL; | |||
| Crystal structure of human CDK8/CYCC in complex with compound 1 (N-[3-tert-butyl-1-(4-methylphenyl)… |
Heteromer P49336; | 100 | 1×0SS; 1×DMS; 9×EDO; 5×FMT; | |||
| Crystal structure of human CDK8-Cyclin C in complex with cortistatin A |
Heteromer P49336; | 100 | 1×C1I; 5×FMT; | |||
| CDK8/Cyclin C in complex with N-(4-chlorobenzyl)isoquinolin-4-amine |
Heteromer P49336; | 100 | 1×MFE; 1×EDO; 5×FMT; | |||
| Crystal structure of human CDK8/CYCC in complex with BI 919811 |
Heteromer P49336; | 100 | 1×JHK; | |||
| CDK8-CYCC IN COMPLEX WITH 5-{5-Chloro-4-[1-(2-methoxy-ethyl)-1,8-diaza-spiro[4.5]dec-8-yl]-pyridin-… |
Heteromer P49336; | 100 | 1×5Y7; 1×EDO; 3×FMT; | |||
| CDK8-CYCC IN COMPLEX WITH 8-(1-Methyl-2,2-dioxo-2,3-dihydro-1H-2l6-benzo[c]isothiazol-5-yl)-[1,6]na… |
Heteromer P49336; | 100 | 1×68U; 2×FMT; | |||
| Crystal structure of human CDK8/CYCC in complex with compound 3 (1-[3-tert-butyl-1-(4-methylphenyl)… |
Heteromer P49336; | 100 | 1×0SU; 1×EDO; 1×FMT; | |||
| Crystal structure of human CDK8/CYCC in complex with compound 7 (1-[3-tert-butyl-1-(4-methylphenyl)… |
Heteromer P49336; | 100 | 1×0SQ; 4×EDO; 7×FMT; | |||
| CDK8/CYCC IN COMPLEX WITH 8-{3-Chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)-phenyl]-pyridin- 4-yl}-2,8-di… |
Heteromer P49336; | 100 | 1×4TV; 2×FMT; | |||
| CDK8-CYCC IN COMPLEX WITH (3-Amino-1H-indazol-5-yl)-[(S)-2-(4-fluoro-phenyl)-piperidin-1-yl]-methan… |
Heteromer P49336; | 100 | 1×6A6; 5×FMT; | |||
| Crystal structure of human CDK8/CYCC in complex with BI-1347 |
Heteromer P49336; | 100 | 1×JH8; | |||
| Crystal structure of human CDK8/CYCC in the DMG-in conformation |
Heteromer P49336; | 100 | 1×FMT; | |||
| Crystal structure of human CDK8/CYCC in complex with compound 2 (tert-butyl [3-({[3-tert-butyl-1-(4… |
Heteromer P49336; | 100 | 1×0SO; | |||
| Crystal structure of human CDK8/CYCC in complex with compound 4 (1-[3-tert-butyl-1-(4-methylphenyl)… |
Heteromer P49336; | 100 | 1×0ST; 1×EDO; | |||
| CDK8-CYCC IN COMPLEX WITH 8-[2-Amino-3-chloro-5-(1-methyl-1H-indazol-5-yl)-pyridin-4-yl]-2,8-diaza-… |
Heteromer P49336; | 100 | 1×5Y8; 1×EDO; 1×FMT; | |||
| CDK8-CYCC IN COMPLEX WITH COMPOUND 17:3-chloro-4-(4-pyridyl)-1H-pyrrole-2-carboxamide |
Heteromer P49336; | 100 | 1×GOL; 1×8D6; | |||
| Human CDK8-CYCC in complex with compound 4: N-methyl-4-(4-pyridyl)-1H-pyrrole-2-carboxamide |
Heteromer P49336; | 100 | 2×GOL; 1×8CC; | |||
| CDK8/CyclinC in complex with drug ETP-50775 |
Heteromer P49336; | 100 | 1×NZ8; 12×FMT; 4×NZ5; | |||
| Structure of the kinase lobe of human CDK8 kinase module |
Heteromer P49336; Q93074; Q9UHV7; | 100.0 | ||||
| Structure of human transcriptional Mediator complex |
Heteromer A0JLT2; O43513; O60244; O75448; O75586; P49336; Q13503; Q15528; Q15648; Q6P2C8; Q93074; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9UHV7; Q9ULK4; Q9Y2X0; Q9Y3C7; | 100 | 4×ZN; | |||
| Structure of the human CDK8 kinase module |
Heteromer P49336; Q93074; Q9UHV7; | 100 | 2×ZN; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4f7n.1.B | monomer | 0.91 | 100.00 | |||
| 5if1.1.B | monomer | 0.58 | 18.53 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 4f7n.1.B | monomer | 0.84 | 100.00 | |||